Last updated on May 2020

Efficacy and Safety of Selonsertib in Participants With Moderate to Advanced Diabetic Kidney Disease


Brief description of study

The primary objective of this study is to evaluate whether selonsertib (SEL) can slow the decline in kidney function, reduce the risk of kidney failure, or reduce the risk of death due to kidney disease in participants with diabetic kidney disease (DKD).

Clinical Study Identifier: NCT04026165

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.